Cellceutix Corporation (OTCQB:CTIX) issued big news this morning that they have received the “thumbs-up” from one of the world’s leading cancer research centers to host the Company’s clinical trials for Kevetrin™. Cellceutix is developing (and posting strong pre-clinical results) Kevetrin™ as an indication for a multitude of cancers including drug-resistant, pancreatic, lung, leukemia and breast cancers. The cancer center was not disclosed, but there are several industry-leading centers in the east/northeast United States. U.S. News recently released their list of the top cancer hospitals in the U.S. The Top 5 included Memorial Sloan-Kettering in New York, NY; Johns Hopkins in Baltimore, MD; and Dana-Farber/Brigham and Women’s in Boston, which will have investors wondering which center will be hosting the trials (if any of these that are close to Cellceutix’s Massachusetts office). The others rounding out the Top 5 were the Mayo Clinic in Rochester, MN and the University of Texas M.D. Anderson Cancer Center in Houston, TX. Read the full Press Release and get a CTIX stock quote.
Other articlesgo to homepage
 |
Markets Take Another Pounding(0)U.S. stocks were lower for a fifth day Thursday, as investors continued to fret about Greece”s future in the euro-zone. The Dow Jones Industrials closed down 156.06 points, or 1.2%, to 12,442.50 The S&P 500 demurred 19.94 points to 1,304.86. The tech-rich Nasdaq Composite Index capsized 60.35 to 2,813.69. Retail giants Wal-Mart and Sears Holdings |
 |
Winning Brands Gets First Order from Canada(0)Winning Brands Corporation (Pink Sheets: WNBD) reported that it has received its first order for delivery of 1000+™ Stain Remover, World’s Most Versatile Cleaning Solution™, to a military facility, in Canada. 1000+ is manufactured by the Niagara Mist Marketing Division of Winning Brands. The first order is for product to be used at a Canadian |
 |
Premiere Opportunities Partners with Flex Fuel Technologies(0)Totowa, New Jersey-based Premiere Opportunities Group, Inc. (OTCQB: PPBL) has signed an advisory agreement with Flex Fuel Technologies Inc. to assist the company with its strategic planning, EPA testing and budget planning for the future introduction of its products into the automotive aftermarket. Flex Fuel Technologies, Inc. has developed a ” bolt on technology,” called |
 |
Pioneers in Regenerative Medicine Reshaping the Landscape of Biotechnology(0)Every industry or sector has pioneers that worked at the forefront of the field to shepherd new technologies into the mainstream. Oncology, for example, took huge steps forward as a result of the efforts of Dr. Sidney Farber, earning him the titles of “the father of the modern era of chemotherapy” and “father of modern |
 |
Overhyped Social Media Stocks Highlight Value in CrowdGather(0)There is a lot of activity surrounding social media stocks with the Initial Public Offering of Facebook (NASDAQ: FB) coming on Friday. The new listing, which could see the company valued at as much as $100 billion, has investors and analysts already concerned that the world’s largest social network could be overvalued from the get-go. |
OTCBB News
read more
Stay Informed
Dana-Farber to Host Cellceutix Trials
Diabetes Rate Growing Exponentially
According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.
0 comments
Add your comment
Commenting is allowed only for registered users.